PFIZER INC
PFEPharma & biotechpfizer.com
Latest available resultsSeptember 27, 2026Quarter · 10-Q filed Nov 3, 2026
Next reportFebruary 1, 2027after close · forecast 0.72 $/share
Revenue
$16.58B
▼ -0.4% vs prior year YoY
Net income
$3.24B
▼ -8.4% vs prior year YoY
EPS
0.56$
▼ -9.7% vs prior year YoY
Net margin
19.6%
▼ -1.7 pp vs prior year YoY
Revenue▼ -0.4%
Margins (% of revenue)GrossOperating N/ANet
Net income▼ -8.4%
EPS▼ -9.7%
Financial statements
View 10-Q filed November 3, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $17.76B | $13.71B | $14.65B | $16.65B | $17.56B | $14.45B | $15.03B | $16.58B | ▼ -0.4% |
| Gross profit | $11.85B | $10.87B | $10.88B | $12.48B | $12.29B | $10.90B | $10.94B | $12.55B | ▲ +0.6% |
| Operating incomenever filed | — | — | — | — | — | — | — | — | — |
| Net income | $410.00M | $2.97B | $2.91B | $3.54B | −$1.65B | $2.69B | −$248.00M | $3.24B | ▼ -8.4% |
| R&Dnever filed | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 0.52 $ | 0.51 $ | 0.62 $ | — | 0.47 $ | -0.04 $ | 0.56 $ | ▼ -9.7% |
| Margins (% of revenue) | |||||||||
| Gross | 66.7 % | 79.3 % | 74.2 % | 74.9 % | 70.0 % | 75.4 % | 72.8 % | 75.7 % | ▲ +0.8 pt |
| Operating | — | — | — | — | — | — | — | — | — |
| Net | 2.3 % | 21.6 % | 19.9 % | 21.3 % | -9.4 % | 18.6 % | -1.6 % | 19.6 % | ▼ -1.7 pt |
| Balance sheet | |||||||||
| Assets | $213.40B | $208.03B | $206.09B | $208.73B | $208.16B | $207.62B | $201.13B | $204.54B | ▼ -2.0% |
| Liabilities | $124.90B | $117.39B | $117.08B | $115.64B | $121.39B | $117.21B | $115.64B | $115.24B | ▼ -0.3% |
| Equity | $88.50B | $90.64B | $89.01B | $93.10B | $86.78B | $90.40B | $85.49B | $89.30B | ▼ -4.1% |
| Cash | $1.04B | $1.43B | $1.64B | $1.34B | $1.14B | $1.70B | $976.00M | $1.82B | ▲ +35.8% |
| Capital | |||||||||
| Shares outstanding | 5.67B | 5.69B | 5.69B | 5.69B | 5.69B | 5.70B | 5.70B | 5.70B | ▲ +0.2% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.